Ripley B J M, Goncalves B, Isenberg D A, Latchman D S, Rahman A
Institute of Child Health, 30 Guildford Street, London WC1N 1EH, UK.
Ann Rheum Dis. 2005 Jun;64(6):849-53. doi: 10.1136/ard.2004.022681.
Raised levels of the cytokines interleukin (IL) 6 and IL10 have been reported in patients with systemic lupus erythematosus (SLE).
To determine if levels of IL6 and IL10 correlate with organ/system-specific disease activity in SLE, using the British Isles Lupus Assessment Group (BILAG) Disease Activity Index.
Levels of IL6 and IL10 in serum samples from 171 patients with SLE and 50 normal controls were determined by enzyme linked immunosorbent assay (ELISA). Levels of cytokines in individual patients with SLE were compared with the presence or absence of active disease in eight organ/systems using the BILAG index.
Levels of IL6 were significantly higher (p = 0.005) in patients with active compared with inactive haematological disease, as scored by the BILAG index. Further analysis showed that this association was dependent on an inverse correlation (p = 0.002, r = -0.26) between IL6 levels and haemoglobin levels in patients with SLE. In contrast, IL10 levels did not correlate with individual organ/system disease activity.
Raised levels of IL6 in SLE may influence the development of anaemia in this disease. These findings are in agreement with an increasing number of studies, which support physiological links between IL6 and anaemia. Importantly, with the exception of the haematological system, our studies do not provide evidence of any individual organ/system which would respond to therapeutic manipulation of either IL6 or IL10 levels.
据报道,系统性红斑狼疮(SLE)患者体内细胞因子白细胞介素(IL)-6和IL-10水平升高。
使用不列颠群岛狼疮评估组(BILAG)疾病活动指数,确定IL-6和IL-10水平是否与SLE中器官/系统特异性疾病活动相关。
采用酶联免疫吸附测定(ELISA)法测定171例SLE患者和50例正常对照血清样本中IL-6和IL-10水平。使用BILAG指数将SLE个体患者的细胞因子水平与八个器官/系统中是否存在活动性疾病进行比较。
根据BILAG指数评分,活动性血液系统疾病患者的IL-6水平显著高于非活动性患者(p = 0.005)。进一步分析表明,这种关联取决于SLE患者IL-6水平与血红蛋白水平之间的负相关(p = 0.002,r = -0.26)。相比之下,IL-10水平与个体器官/系统疾病活动无关。
SLE患者IL-6水平升高可能影响该疾病贫血的发生。这些发现与越来越多支持IL-6与贫血之间生理联系的研究一致。重要的是,除血液系统外,我们的研究没有提供任何个体器官/系统会对IL-6或IL-10水平的治疗性调控产生反应的证据。